The loss of therapeutic efficacy of Lm-LLO-CD105A upon downregulation of CD105 in Renca tumor cells (Figure 7C) was unexpected as we had seen a significant reduction in tumor-associated vasculature. The gene discussed is ENG; the disease is neoplasm.